Seattle-area microbiome and diagnostics startup Viome Life Sciences is elevating more money, in keeping with a brand new regulatory submitting.
The submitting reveals $67 million raised of a bigger spherical. We’ve reached out to Viome to be taught extra and can replace once we hear again. Replace: Viome corroborated the funding quantity in an announcement Tuesday.
Viome sells a equipment to find out the microbial composition of stool samples and recommends “precision” dietary supplements and probiotics based mostly on a person’s readout. This July, the corporate launched a “Full Physique Intelligence Check” that additionally analyzes saliva and blood samples. Earlier this yr movie star and socialite Paris Hilton grew to become a Viome model ambassador.
The corporate can be growing a diagnostic take a look at for oral and throat most cancers that has obtained breakthrough gadget designation from the FDA, enabling it to obtain expedited evaluation previous to approval.
In April 2021, the six-year outdated firm mentioned it had greater than 200,000 clients and was anticipating income to hit $100 million in 2022.
Viome is the seventh enterprise of founder and CEO Naveen Jain. Jain is the founder and former CEO of InfoSpace and likewise co-founded public data agency Intelius, in addition to Moon Specific, which goals to take paying clients to the moon.
Viome raised $54 million raised in November, bringing its complete funding to greater than $125 million.
Viome’s earlier buyers embrace Khosla Ventures, WestRiver Group, Glico, Doctor Companions, Ocgrow Ventures and Daring Capital Group. All these buyers participated within the new funding spherical, which was led by Daring Capital. Salesforce CEO Marc Benioff was an early investor within the firm.